methoxyamine has been researched along with Ovarian Neoplasms in 1 studies
methoxyamine: analytical reagent for aldehydes and ketones; strong irritant, can probably produce methemoglobinemia; RN given refers to parent cpd; structure
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To improve the treatment of women with ovarian cancer, we are investigating the modulation of a prominent DNA-damaging agent, temozolomide, by manipulating the DNA base excision repair (BER) pathway via BER inhibitor, methoxyamine, and overexpression of N-methylpurine DNA glycosylase (MPG)." | 1.34 | Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide. ( Fishel, ML; He, Y; Kelley, MR; Smith, ML, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fishel, ML | 1 |
| He, Y | 1 |
| Smith, ML | 1 |
| Kelley, MR | 1 |
1 other study available for methoxyamine and Ovarian Neoplasms
| Article | Year |
|---|---|
Manipulation of base excision repair to sensitize ovarian cancer cells to alkylating agent temozolomide.
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Base Sequence; Cell Line, Tumor; Dacarbazine; DNA Dama | 2007 |